Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Lin

Showing results (241-250 of 352) with videos related to

Pageof 36
Sort By:
Journal of Cellular Physiology|January 10, 2019
Arecoline N-oxide regulates oral squamous cell carcinoma development through NOTCH1 and FAT1 expressionsTzer-Min Kuo, Srinivasan Nithiyanantham, Chi-Pin Lee, et al.
Oncology|May 3, 2013
The Aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiformePei-Ying Lee, Chi-Long Chen, Zhong-Zhe Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 11, 2019
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinomaYu-Yun Shao, Tsung-Hao Liu, Chiun Hsu, et al.
Frontiers in Immunology|November 9, 2018
A Metalloprotease Homolog Venom Protein From a Parasitoid Wasp Suppresses the Toll Pathway in Host HemocytesZhe Lin, Yang Cheng, Rui-Juan Wang, et al.
The Oncologist|July 25, 2012
Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: an east asian population-based studyZhong-Zhe Lin, Wen-Yi Shau, Yu-Yun Shao, et al.
Briefings in Bioinformatics|October 2, 2023
TransIntegrator: capture nearly full protein-coding transcript variants via integrating Illumina and PacBio transcriptomesZhe Lin, Yangmei Qin, Hao Chen, et al.
Expert Review of Gastroenterology & Hepatology|May 29, 2019
Considerations of heterogeneity in clinical trials for hepatocellular carcinomaTsung-Hao Liu, Yu-Yun Shao, Li-Chun Lu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: correlation with clinicopathologic features and patient survivalYing-Chun Shen, Fu-Chang Hu, Yung-Ming Jeng, et al.
Cancers|October 13, 2021
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II TrialsBang-Bin Chen, Zhong-Zhe Lin, Yu-Yun Shao, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular CarcinomaBang-Bin Chen, Yu-Yun Shao, Zhong-Zhe Lin, et al.
Pageof 36

Showing results (241-250 of 352) with videos related to

Sort By:
Pageof 36
Journal of Cellular Physiology|January 10, 2019
Arecoline N-oxide regulates oral squamous cell carcinoma development through NOTCH1 and FAT1 expressionsTzer-Min Kuo, Srinivasan Nithiyanantham, Chi-Pin Lee, et al.
Oncology|May 3, 2013
The Aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiformePei-Ying Lee, Chi-Long Chen, Zhong-Zhe Lin, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 11, 2019
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinomaYu-Yun Shao, Tsung-Hao Liu, Chiun Hsu, et al.
Frontiers in Immunology|November 9, 2018
A Metalloprotease Homolog Venom Protein From a Parasitoid Wasp Suppresses the Toll Pathway in Host HemocytesZhe Lin, Yang Cheng, Rui-Juan Wang, et al.
The Oncologist|July 25, 2012
Survival following surgery with or without adjuvant chemotherapy for stage I-IIIA non-small cell lung cancer: an east asian population-based studyZhong-Zhe Lin, Wen-Yi Shau, Yu-Yun Shao, et al.
Briefings in Bioinformatics|October 2, 2023
TransIntegrator: capture nearly full protein-coding transcript variants via integrating Illumina and PacBio transcriptomesZhe Lin, Yangmei Qin, Hao Chen, et al.
Expert Review of Gastroenterology & Hepatology|May 29, 2019
Considerations of heterogeneity in clinical trials for hepatocellular carcinomaTsung-Hao Liu, Yu-Yun Shao, Li-Chun Lu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 5, 2009
Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: correlation with clinicopathologic features and patient survivalYing-Chun Shen, Fu-Chang Hu, Yung-Ming Jeng, et al.
Cancers|October 13, 2021
Early Changes in DCE-MRI Biomarkers May Predict Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma after Sorafenib Failure: Two Prospective Phase II TrialsBang-Bin Chen, Zhong-Zhe Lin, Yu-Yun Shao, et al.
Diagnostics (Basel, Switzerland)|August 27, 2021
Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular CarcinomaBang-Bin Chen, Yu-Yun Shao, Zhong-Zhe Lin, et al.
Pageof 36